AIHTA - Publications - Search - Olaparib (Lynparza®) for metastatic castration-resistant prostate cancer (mCRPC)

Grössmann, N. (2020): Olaparib (Lynparza®) for metastatic castration-resistant prostate cancer (mCRPC). Oncology Fact Sheet Nr. 23.

[thumbnail of Oncology Fact Sheet Nr.23.pdf]
Preview
PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
86kB

Item Type:Oncology Fact Sheet
Subjects:QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
QZ Pathology > QZ 200-380 Neoplasms.Cysts
WB Practice of medicine > WB 300-962 Therapeutics
WJ Urogenital system > WJ 700-875 Male genitalia
Language:English
Series Name:Oncology Fact Sheet Nr. 23
Deposited on:29 Oct 2020 12:38
Last Modified:29 Oct 2020 12:38

Repository Staff Only: item control page